Home
Scholarly Works
MA09.03 Cisplatin/Pemetrexed + Durvalumab +/-...
Conference

MA09.03 Cisplatin/Pemetrexed + Durvalumab +/- Tremelimumab in Pts with Advanced Non-Squamous NSCLC: A CCTG Phase IB Study - IND.226

Authors

Juergens R; Hao D; Laurie S; Mates M; Tehfe M; Bradbury P; Kollmannsberger C; Ellis P; Hilton J; Brown-Walker P

Volume

12

Pagination

pp. s392-s393

Publisher

Elsevier

Publication Date

January 1, 2017

DOI

10.1016/j.jtho.2016.11.445

Conference proceedings

Journal of Thoracic Oncology

Issue

1

ISSN

1556-0864

Contact the Experts team